Ali Zarrin

Title: Innovations by Ali Zarrin

Introduction

Ali Zarrin is an accomplished inventor based in Brisbane, CA (US). He has made significant contributions to the field of medical research, particularly in the treatment of inflammatory diseases. With a total of 2 patents, Zarrin's work focuses on novel receptor-ligand interactions that have the potential to transform therapeutic approaches.

Latest Patents

Zarrin's latest patents include methods of treating inflammatory diseases by administering anti-PILR-alpha antibody. This patent describes a novel receptor-ligand interaction and agents that may modify and/or block this interaction. The methods, uses, reagents, and kits for modulating ligand activities related to its interaction with the novel receptor are disclosed. Additionally, therapeutic uses of reagents in treating inflammation-related disorders are also highlighted. Another significant patent involves methods for enhancing pathogen clearance by blocking its interaction with paired immunoglobulin-like type 2 receptor (PILR)α. This patent similarly describes a novel receptor-ligand interaction and agents that may modify and/or block the interaction, along with therapeutic applications.

Career Highlights

Ali Zarrin is currently employed at Genentech, Inc., a leading biotechnology company known for its innovative approaches to drug development. His work at Genentech has allowed him to collaborate with other talented professionals in the field, further enhancing his contributions to medical science.

Collaborations

One of Zarrin's notable coworkers is Yonglian Sun. Their collaboration exemplifies the teamwork that drives innovation in research and development.

Conclusion

Ali Zarrin's innovative work in the field of inflammatory disease treatment showcases his dedication to advancing medical science. His patents reflect a commitment to developing novel therapeutic methods that could significantly impact patient care.